Why Choose Private Prescription for Wegovy 1.7mg?
Private vs NHS Route for Wegovy 1.7mg Access
The NHS pathway for Wegovy 1.7mg requires GP referral to specialist weight management services, often involving 6+ month waiting lists and strict eligibility criteria under NICE TA875. Many patients find themselves caught between doses, unable to progress their treatment timeline effectively. Private prescription through EverydayMeds eliminates these barriers entirely — no GP referral needed, no specialist waiting lists, and the same genuine Novo Nordisk Wegovy 1.7mg that NHS patients receive.
Your clinical assessment takes just 3 minutes online, with prescriber review typically completed within 3 working days (express 24-hour service available). This means you can maintain your dose escalation schedule without interruption, crucial when transitioning from 1mg to this important pre-maintenance level. The private route costs £139.99 per Wegovy 1.7mg pen, providing certainty and control over your weight management journey without compromising on safety or efficacy.
Wegovy 1.7mg Pricing and Bundle Options
Individual Wegovy 1.7mg pens cost £139.99 through our private prescription service, with new customers applying code FIRST40 at checkout and returning customers using DOSE25 for optimal pricing. This transparent pricing structure eliminates the uncertainty of NHS prescription charges and potential supply interruptions. Many patients at the 1.7mg stage benefit from our Elevate Duo bundle, combining 1.7mg with 2.4mg maintenance dosing for £369.99, ensuring seamless progression to your final treatment level.
For those requiring extended time at the 1.7mg dose, our Consistency 1.7mg bundle provides two pens for £309.99, offering 8 weeks of stable dosing. The Elevate Trio bundle (1mg, 1.7mg, 2.4mg) at £499.99 suits patients stepping up from 1mg level, providing 12 weeks of progressive treatment. All bundles include the same cold-chain delivery and clinical support, with discount codes applied at checkout to reach these competitive prices.
Clinical Evidence Supporting Wegovy 1.7mg Efficacy
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with many experiencing accelerated results during the 1.7mg phase (Wilding et al., NEJM, 2021). This dose represents weeks 13-16 of treatment, often the period where appetite suppression becomes most pronounced before maintenance level.
STEP 5 trial data showed sustained weight management at 2 years, whilst the recent SELECT trial revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management. The 1.7mg dose forms a crucial bridge in the escalation protocol, preparing patients for long-term 2.4mg maintenance therapy.
How Wegovy 1.7mg Mechanisms Support Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, becoming increasingly effective as doses escalate to 1.7mg levels. At this stage, patients typically experience significant appetite reduction and enhanced satiety after smaller meals, with many reporting decreased food cravings and improved portion control. The medication works on brain appetite centres, particularly in the hypothalamus, to regulate hunger signals more effectively than at lower doses. This 1.7mg concentration often represents the point where patients notice substantial changes in their relationship with food, preparing them for successful maintenance phase outcomes. The once-weekly injection schedule remains consistent, but the therapeutic impact intensifies as you approach optimal dosing levels.
Streamlined Ordering Process for Wegovy 1.7mg
Ordering Wegovy 1.7mg through private prescription takes just 3 minutes via our online clinical assessment, covering your medical history, current medications, and weight management goals. Our UK-based prescribers review your assessment within 3 working days (express 24-hour service available), ensuring clinical appropriateness before approving your prescription-only medicine. Once approved, your Wegovy 1.7mg ships via next-day delivery in temperature-controlled packaging, maintaining the 2-8°C cold-chain requirements throughout transit. Payment processing occurs securely at checkout, with discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied to reach our competitive £139.99 pricing. This efficient process ensures minimal disruption to your dose escalation schedule, particularly important when transitioning between treatment phases.
Storage and Practical Considerations for Wegovy 1.7mg
Store your Wegovy 1.7mg pen in the fridge at 2-8°C until first use, though it remains stable for up to 6 weeks at room temperature below 30°C once removed — a significant advantage over some competitor treatments. The FlexTouch pen design delivers precise 1.7mg dosing with clear visual confirmation, whilst the once-weekly schedule maintains treatment convenience as you approach maintenance levels. Never skip doses or attempt to accelerate beyond the prescribed escalation schedule, as the 1.7mg level serves specific physiological adaptation purposes before reaching 2.4mg maintenance. Rotate injection sites between your thigh, upper arm, or abdomen to minimize potential site reactions, particularly important as doses increase in concentration. Record your injection dates and monitor your response, as this 1.7mg phase often provides valuable insights into your optimal long-term maintenance approach.
Why Wegovy 1.7mg Represents Your Pre-Maintenance Milestone
Reaching Wegovy 1.7mg signifies you're just one dose level away from 2.4mg maintenance therapy, making this a pivotal stage in your weight management journey. Many patients experience their most significant appetite changes during weeks 13-16, as the 1.7mg concentration approaches therapeutic optimization levels. This creates an ideal opportunity to establish sustainable eating patterns and lifestyle modifications that will support your long-term maintenance phase success.
Private prescription access ensures you can progress to 2.4mg maintenance without NHS-related delays or supply uncertainties, crucial for maintaining treatment momentum. Our Elevate Duo bundle specifically addresses this transition, providing both 1.7mg and 2.4mg pens for seamless progression at £369.99, eliminating the need for separate assessments or potential gaps in treatment continuity.
Secure Your Wegovy 1.7mg Private Prescription Today
Complete your clinical assessment now to access Wegovy 1.7mg for £139.99, with new customer code FIRST40 or returning customer code DOSE25 applied at checkout for optimal pricing. Consider our Elevate Duo bundle for seamless progression to maintenance, or Consistency bundles if extended time at 1.7mg better suits your individual response pattern. Our GPhC-registered pharmacy (#9012878) ensures the same quality standards as NHS supply, with superior convenience and treatment continuity. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your assessment and secure your prescription-only medicine through our streamlined private service. Join thousands of patients who've chosen private prescription for reliable, timely access to their weight management medication.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
